Table 2

Region-specific factors surrounding electronic inhalable nicotine products

JapanRepublic of KoreaEnglandCanadaUSA
Year that contemporary HTPs were first introduced20142017201620172019
Availability and sales of HTPThe HTP market is diverse and includes many brands and device subtypes, including tobacco stick-based devices and several ‘hybrid’ devices.
In 2020, comprised 99.5% of ‘Smokeless Tobacco, E-Vapour Products and Heated Tobacco’ sales*.
Tobacco stick-based devices and ‘hybrid’ devices are available for purchase.
In 2020, comprised 86.7% of ‘Smokeless Tobacco, E-Vapour Products and Heated Tobacco’ sales*.
Opening of a London-based IQOS boutique storefront and has expanded to other regions.
In 2020, comprised 3.4% of ‘Smokeless Tobacco, E-Vapour Products and Heated Tobacco’ sales*.
IQOS and glo have been marketed in major cities.
In 2020, comprised 4.5% of ‘Smokeless Tobacco, E-Vapour Products and Heated Tobacco’ sales*.
IQOS has been marketed in a limited capacity and authorised to the market through FDA’s premarket tobacco product application process. Loose-leaf vapourisers (eg, PAX) are accessible for purchase as well, and Ploom TECH (rebranded as Logic Vapeleaf) is sold online in six states.
In 2020, comprised 0.1% of ‘Smokeless Tobacco, E-Vapour Products and Heated Tobacco’ sales*.
Sales of NVPIn 2020, comprised 0.4% of ‘Smokeless Tobacco, E-Vapour Products and Heated Tobacco’ sales*.In 2020, comprised 3.1% of ‘Smokeless Tobacco, E-Vapour Products and Heated Tobacco’ sales*.In 2020, comprised 96.4% of ‘Smokeless Tobacco, E-Vapour Products and Heated Tobacco’ sales*.In 2020, comprised 81.6% of ‘Smokeless Tobacco, E-Vapour Products and Heated Tobacco’ sales*.In 2020, comprised 44.8% of ‘Smokeless Tobacco, E-Vapour Products and Heated Tobacco’ sales*.
Use of cannabisIn 2021, the past-year prevalence of cannabis use among individuals aged 15–64 years old was estimated at 0.1%†.Recent measures of prevalence of use are lacking; however, just 8072 illicit cannabis plants were eradicated in 2019, equivalent to 0.2% of that in the USA‡.In 2018, the past-year prevalence of cannabis use among individuals aged 15–64 years old was estimated at 7.6%†.In 2017, the past-year prevalence of cannabis use among individuals aged 15–64 years old was estimated at 14.8%†.In 2018, the past-year prevalence of cannabis use among individuals aged 15–64 years old was estimated at 19.4%†.
NomenclatureVerb: preferred Japanese verb for smoking tobacco approximately translates to ‘inhaling a tobacco product’, which further complicates differentiating HTP and conventional cigarette use.Verb: preferred Korean verb for smoking tobacco approximately translates to ‘inhaling a tobacco product’.
Use of similar terms: Korean legal term for HTPs translates to ‘cigarette type electronic tobacco’, and NVPs often are referred just as ‘electronic tobacco’.
  • *According to Euromonitor International sales data (https://www.euromonitor.com).

  • †According to the United Nations Office on Drugs and Crime’s World Drug Report 2021 (https://dataunodc.un.org/data/drugs/Prevalence-general).

  • ‡United Nations Office on Drugs and Crime, 2021. Drug Market Trends: Cannabis & Opioids. World Drug Report 2021.

  • FDA, Food and Drug Administration; HTPs, heated tobacco products; NVPs, nicotine vaping products.